GSK and Theravance announce results of two pivotal Phase III studies for RelovairTM in COPD
GSK and Theravance announce results of two pivotal Phase III studies for RelovairTM in COPD
Jun 02, 2011
Innoviva
Minimum 15 minutes delayed. Source: LSEG
Sign up to receive important email alerts & updates from Innoviva.
Sign up now